The Role of miR-122 in the Hepatocellular Carcinogenesis Talk delivered at 3rd Annual Congress of the European Society for Translational Medicine, Vienna, Austria on 1-4 September, 2015 <span style="display: inline-block; width: 0px; overflow: hidden; line-height: 0;" data-mce-type="bookmark" class="lazy lazy-hidden mce_SELRES_start"></span><span style="display: inline-block; width: 0px; overflow: hidden; line-height: 0;" data-mce-type="bookmark" class="mce_SELRES_start"></span> Related Posts New Hopes In Cancer Treatment Angiogenesis & tumor microenvironment as targets for cancer prevention Therapeutic exploitation of the cancer glycome: a drug discovery study.. CancerEUSTMEUSTM Conference 2015EUSTM CongressEUSTM-2015gastroenterologyhepatic cancerHepatocellular cancerHepatocellular carcinomahepatologymiR-122oncology
